Source: Annual Congress 2002 - Cardiovascular aspects of sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bednarek, R. Plywaczewski, L. Jonczak, M. Polakowska, P. Kurjata, W. Kupsc, J. Zielinski (Warsaw, Poland). OSAS and the incidence of cardiovascular disorders. Eur Respir J 2002; 20: Suppl. 38, 1860

Member's Comments

No comment yet.

Related content which might interest you: The association between COPD and cardiovascular disorders Source: International Congress 2017 – COPD and comorbid cardiovascular diseases Year: 2017 The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002 Sleep-related breathing disorders: impact on mortality of cerebrovascular disease Source: Eur Respir J 2004; 24: 267-272 Year: 2004 The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea Source: Eur Respir J 2001; 17: 573-574 Year: 2001 Metabolic effects of OSAS and cardiovascular risk Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007 Hypoxia and cardiovascular comorbidity in the ESADA OSA patients with insomnia symptoms Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018 Presence of cardiovascular risk markers in OSAS Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007 OSA and cardiovascular risk in women Source: 5th Sleep and Breathing Conference Year: 2019 Prevalence of non cardiovascular disorders in patients with obstructive sleep apnoea and in ”healthy“ snorers Source: Eur Respir J 2003; 22: Suppl. 45, 92s Year: 2003 Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment Source: Eur Respir J 2002; 20: 1511-1518 Year: 2002 Prevalence of undiagnosed COPD in patients with established cardiovascular diseases Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012 Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007 Obstructive sleep apnoea doesn‘t increase risk of cardiovascular morbidity and mortality in patients with arterial hypertension Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea Year: 2008 Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006